1/3

FIEO Registered Export Ready

RABOZ-LSP

Name: RABOZ-LSP
SKU: 8238678
Availability: InStoreOnly

Sold by freedom healthcare private limited · Brand Owner, Distributor, Wholesaler, Women Entrepreneur · Jaipur, Rajasthan, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for freedom healthcare private limited.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Jaipur Dispatch on request FIEO member

freedom healthcare private limited

Brand Owner, Distributor, Wholesaler, Women Entrepreneur · Jaipur, Rajasthan, India

In the vibrant tapestry of healthcare, Freedom Healthcare Private Limited emerged as a beacon of hope in 2013, when Jitender Mohan Kamra, driven by a profound desire to serve humanity with quality medication, laid the foundation of the company. Nestled in the heart of Rajasthan, the company swiftly expanded its wings, establishing a robust presence in Delhi, Punjab, and Haryana. Jitender Mohan Kamra's vision was simple yet profound – to bring about a positive change in people's lives through accessible and reliable healthcare. With unwavering dedication, Freedom Healthcare began its journey, crafting a legacy that transcended business and resonated with compassion. Over the years, Freedom Healthcare not only garnered trust and loyalty but also became synonymous with excellence in pharmaceuticals. The company's commitment to quality and integrity endeared it to healthcare professionals and communities alike. As the years rolled by, a heartwarming twist unfolded in the company's narrative. Jitender Mohan Kamra's children, inspired by their father's noble cause, embraced the legacy with open arms. Fueled by the same passion and commitment, they joined the company, becoming torchbearers of the Freedom Healthcare ethos. The legacy of Freedom Healthcare is no longer confined to a single visionary; it now thrives through the collective efforts of a family united by a shared purpose. The seamless blend of tradition and innovation has propelled the company to new heights, ensuring

Registered address: Jaipur, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

2013

Employees

31–50

GST

08AACCF4091M1ZB

IEC code

AACCF4091M

Export markets

Global markets

GlobalLinker Member Since

Dec 2023

Turnover

Less than $50,000

Incorporation Type

On request

Certifications & Awards

Product details

What are the specifications of this product?

Overview

RABOZ-LSP stands as the definitive solution for gastrointestinal challenges like diabetic gastroparesis, IBS, gastric ulcer, GERD, and duodenal ulcer. Our comprehensive formula is meticulously crafted to provide unparalleled relief and healing, backed by proven efficacy in addressing these conditions. Embrace confidence in managing GI health with RABOZ-LSP, your strategic ally in delivering effective relief and comfort. Join the ranks of satisfied individuals and businesses relying on RABOZ-LSP for optimal GI wellness and seamless digestive care.

Product Description

FOR G.I. PROBLEMS LIKE

• Diabetic gastroparesis IBS

• Gastric ulcer & GERD

• Duodenal ulcer

Raboz-LSP

Rabeprazole Sodium 20 mg + Levosulpiride 75 mg SR Cap.

The Combined Synergy of APPROVED GI Regulator & Potent PPI

PROLONGED SAFETY -Effective as a long te-rm Maintenance Therapy Safe and effective for long-term maintenance therapy of reflux esophagitis

Intern Med. 2011;50(11)

Levosulpiride Remarkably Superior to Domperidone & Other Prokinetics

Exerts prokinetic action through dual mechanism:

1) as a D(2) dopamine receptor antagonist and 2) as a serotonin 5HT(4) receptor agonist,

At a dosage of 75 mg SR daily, levosulpiride accelerates gastric and gallbladder emptying More effective in reducing symptoms of dyspepsia, as compared to other dopamine antagonists*

*Gastroenterol Hepatol. 2010 Oct;33(8)

Raboz-LSP

The Dependable PPI with Long Standing Prokinetic

Description provided by freedom healthcare private limited.

Specifications

Generic Name	Rabeprazole Sodium + Levosulpiride
Dosage Strength	Rabeprazole Sodium 20 mg, Levosulpiride 75 mg SR
Dosage Form	Capsule (Sustained Release)
Indications	Diabetic gastroparesis, IBS, Gastric and duodenal ulcers, GERD
Pharmacological Class	Proton Pump Inhibitor (PPI) and Prokinetic Agent
Release Mechanism	Sustained release for prolonged action
Administration Route	Oral
Treatment Duration	Approved for long-term maintenance therapy
Regulatory Status	Approved GI regulator and PPI combination
Storage	Store in a cool, dry place away from direct sunlight

Use cases

Category	commercial equipment > commercial robots > logistics robots
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing RABOZ-LSP. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does RABOZ-LSP improve gastric motility in diabetic gastroparesis patients?

A: RABOZ-LSP contains Levosulpiride 75 mg SR which acts as a dopamine D2 receptor antagonist and serotonin 5HT4 receptor agonist, accelerating gastric and gallbladder emptying, thereby improving motility impaired by diabetic gastroparesis.

Q: What makes RABOZ-LSP safer for long-term maintenance therapy in GERD compared to other medications?

A: RABOZ-LSP combines Rabeprazole, a potent PPI known for minimal long-term side effects, with Levosulpiride’s prokinetic properties, allowing prolonged therapy that effectively controls acid reflux while enhancing GI motility, reducing risks of chronic GERD complications.

Q: Is RABOZ-LSP more effective than domperidone-based treatments for gastrointestinal dyspepsia?

A: Yes, clinical evidence indicates that Levosulpiride in RABOZ-LSP offers superior symptom control for dyspepsia compared to domperidone, due to its dual receptor activity and sustained release formulation.

Q: Can RABOZ-LSP be used for both ulcer treatment and functional GI disorders like IBS?

A: RABOZ-LSP’s formulation is effective against acid-related ulcers due to Rabeprazole’s acid suppression, while Levosulpiride addresses motility and dyspeptic symptoms common in IBS, making it suitable for both ulcer treatment and managing IBS symptoms.

Q: What are the key therapeutic advantages of the sustained-release Levosulpiride in RABOZ-LSP?

A: The sustained-release (SR) formulation ensures a steady plasma concentration of Levosulpiride, leading to prolonged prokinetic effects that enhance gastric emptying and symptom control with once-daily dosing, improving patient compliance.

Question not answered? Ask sellers directly — typical response within 4 hours.